Valuation Sharp Therapeutics Corp.

Stocks

Market Closed - Toronto S.E. 11:31:12 2026-09-21 EDT			5-day change	1st Jan Change
1.370 ^CAD	-.--%		-.--%	-45.20%

08-28	Sharp Therapeutics Corp. Reports Earnings Results for the Half Year Ended June 30, 2026	CI
07-29	Sharp Therapeutics Corp. announced that it has received CAD 1.365 million in funding from Newlin Investment Company 1, LLC	CI

Data adjusted to current consolidation scope

Fiscal Period: December	2023	2024	2025
Market Cap ¹	-	22.45	54.83
Change	-	-	144.21%
Enterprise Value (EV) ¹	-	20.28	55.16
Change	-	-	171.93%
P/E	-0.03x	-2.2x	-8.7x
PBR	-0.01x	8.69x	-311x
PEG	0x	0x	0.2x
Capitalization / Revenue	-	-	-
EV / Revenue	-	-	-
EV / EBITDA	-	-8.03x	-10x
EV / EBIT	-	-7.98x	-10x
EV / FCF	-	-	-
FCF Yield	-	-	-
Dividend per Share ²	-	-	-
Rate of return	-	-	-
EPS ²	-25.62	-0.3624	-0.21
Distribution rate	-	-	-
Net sales	-	-	-
EBITDA ¹	-2.238	-2.525	-5.499
EBIT ¹	-2.268	-2.541	-5.513
Net income ¹	-3.565	-3.261	-6.174
Net Debt ¹	12.22	-2.169	0.3259
Reference price ²	0.7956	0.7956	1.8269
Nbr of stocks (in thousands)	-	28,221	30,013
Announcement Date	11/1/24	4/24/25	4/17/26

¹USD in Million²USD

Estimates

Add to a list 0 selected To use this feature you must be a member Log in Sign up	P/E (Y)	EV / Sales (Y)	EV / EBITDA (Y)	Dividend Yield (Y)	Capi.($)
SHARP THERAPEUTICS CORP.	-	-	-	-	30.35M
WUXI APPTEC CO., LTD.	21.73x	7.71x	15.48x	1.37%	74.16B
ARGENX SE	29.82x	8.57x	26.7x	0.04%	57.39B
LONZA GROUP AG	32.98x	5.93x	17.77x	0.98%	47.64B
REVOLUTION MEDICINES, INC.	-21.31x	230.81x	-22.97x	-.--%	44.29B
IQVIA HOLDINGS INC.	33.26x	3.23x	13.97x	-.--%	42.5B
BEONE MEDICINES AG	46.77x	5.41x	29.66x	-.--%	40.71B
CELLTRION, INC.	27.63x	7.93x	20.48x	0.41%	30.97B
WUXI BIOLOGICS (CAYMAN) INC.	32.99x	7.05x	18.3x	-.--%	28.53B
BIONTECH SE	-15.1x	5.68x	-7.14x	-.--%	24.34B
Average	20.98x	31.37x	12.47x	0.31%	39.06B
Weighted average by Cap.	22.27x	32.04x	13.55x	0.42%